MEPs and Heart Failure Policy Network launch Written Declaration on heart failure

News & Events

21 October 2016

Twenty MEPs have initiated a new Written Declaration on heart failure in the European Parliament, one of most significant dedicated policy actions in Europe yet initiated for this costly and prevalent condition. Supporting MEPs gathered with patient representatives and expert figures from all over Europe to show their support for the Declaration, and to discuss the urgent challenges this condition poses to health systems in Europe.

Under European Union rules, Members of the European Parliament (MEPs) can pass formal Written Declarations on specific topics through the Parliament provided at least half of all MEPs agree to sign it, following which the Declaration is endorsed and officially raised with the European Commission. Written Declarations often result in specific actions on the part of the Commission, and many raise considerable awareness of their given topics among decision-makers at both European and national levels.

The Heart Failure Policy Network worked closely with initiator and parliamentary host MEP Annie Schreijer Pierik (Netherlands, EPP) to bring together an informative and interactive event to kick-start a five-month joint campaign by initiating MEPs, the Network and many other supporters across Europe. All parties will be working to secure the requisite support and signatories to the Declaration in the European Parliament.

The event was attended by representatives of more than 18 European and national organisations from patient advocacy, NGO sector, professional societies, and other policy commentators.

Speakers included:

Heart failure is a highly prevalent and costly condition but, to date, few governments have afforded it much priority or dedicated policy focus. The Written Declaration will be formally tabled in early November 2016, and will request that the European Commission ensure the EU plays a more engaged and supportive role in driving a coherent, strategic European response to heart failure. The Commission will be asked to:

Find out more about on the Written Declaration project page.


More from News & Events

Strategic consensus on heart failure in Portugal launched
Strategic consensus on heart failure in Portugal launched...
06 October 2020
The HFPN has collaborated with the Institute of Health Sciences of the Catholic University of Portugal to develop a strategic consensus on heart failure in Portugal....
Read article
HFPN presents Portuguese work at Portuguese Society of Cardi
HFPN presents Portuguese work at Portuguese Society of Cardi...
24 January 2020
The HFPN presented recent work at the Annual Meeting of the Heart Failure Study Group of the Portuguese Society of Cardiology....
Read article
The Heart Failure Policy Network is made possible with financial support from Novartis Pharma, AstraZeneca and Vifor Pharma. The content produced by the Network is non-promotional and not biased to any specific treatment or therapy. All outputs are guided and endorsed by the Network’s members.